140 related articles for article (PubMed ID: 31095781)
81. Antitumor effect of
Pereira GLDC; Almeida TC; Seibert JB; Amparo TR; Soares RDOA; Rodrigues IV; Bianco de Souza GH; Dos Santos ODH; da Silva GN
Nat Prod Res; 2021 Dec; 35(23):5238-5242. PubMed ID: 32241181
[TBL] [Abstract][Full Text] [Related]
82. The Cytotoxicity Effect of Resveratrol: Cell Cycle Arrest and Induced Apoptosis of Breast Cancer 4T1 Cells.
Wu H; Chen L; Zhu F; Han X; Sun L; Chen K
Toxins (Basel); 2019 Dec; 11(12):. PubMed ID: 31847250
[TBL] [Abstract][Full Text] [Related]
83. Comparative Analysis of the Antitumor Activity of Cis- and Trans-Resveratrol in Human Cancer Cells with Different p53 Status.
Leischner C; Burkard M; Michel A; Berchtold S; Niessner H; Marongiu L; Busch C; Frank J; Lauer UM; Venturelli S
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577057
[TBL] [Abstract][Full Text] [Related]
84. DNA damage-inducible gene, UNC5A, functions as a tumor-suppressor in bladder cancer.
Zhu Y; Yu M; Chen Y; Wang Y; Wang J; Yang C; Bi J
Tumour Biol; 2014 Jul; 35(7):6887-91. PubMed ID: 24737586
[TBL] [Abstract][Full Text] [Related]
85. Review about the multi-target profile of resveratrol and its implication in the SGK1 inhibition.
Catalogna G; Moraca F; D'Antona L; Dattilo V; Perrotti G; Lupia A; Costa G; Ortuso F; Iuliano R; Trapasso F; Amato R; Alcaro S; Perrotti N
Eur J Med Chem; 2019 Dec; 183():111675. PubMed ID: 31539779
[TBL] [Abstract][Full Text] [Related]
86. Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells.
Florio R; De Filippis B; Veschi S; di Giacomo V; Lanuti P; Catitti G; Brocco D; di Rienzo A; Cataldi A; Cacciatore I; Amoroso R; Cama A; De Lellis L
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768301
[TBL] [Abstract][Full Text] [Related]
87. Discovery of New 2-Phenylamino-3-acyl-1,4-naphthoquinones as Inhibitors of Cancer Cells Proliferation: Searching for Intra-Cellular Targets Playing a Role in Cancer Cells Survival.
Benites J; Valderrama JA; Contreras Á; Enríquez C; Pino-Rios R; Yáñez O; Buc Calderon P
Molecules; 2023 May; 28(11):. PubMed ID: 37298798
[TBL] [Abstract][Full Text] [Related]
88. Differential Response of Lung Cancer Cells, with Various Driver Mutations, to Plant Polyphenol Resveratrol and Vitamin D Active Metabolite PRI-2191.
Maj E; Maj B; Bobak K; Gos M; Chodyński M; Kutner A; Wietrzyk J
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652978
[TBL] [Abstract][Full Text] [Related]
89. Genome-Wide Screens Reveal that Resveratrol Induces Replicative Stress in Human Cells.
Benslimane Y; Bertomeu T; Coulombe-Huntington J; McQuaid M; Sánchez-Osuna M; Papadopoli D; Avizonis D; Russo MST; Huard C; Topisirovic I; Wurtele H; Tyers M; Harrington L
Mol Cell; 2020 Sep; 79(5):846-856.e8. PubMed ID: 32755594
[TBL] [Abstract][Full Text] [Related]
90. Resveratrol as an Enhancer of Apoptosis in Cancer: A Mechanistic Review.
Ashrafizadeh M; Taeb S; Haghi-Aminjan H; Afrashi S; Moloudi K; Musa AE; Najafi M; Farhood B
Anticancer Agents Med Chem; 2021; 21(17):2327-2336. PubMed ID: 33081687
[TBL] [Abstract][Full Text] [Related]
91. NVX-412, a new oncology drug candidate, induces S-phase arrest and DNA damage in cancer cells in a p53-independent manner.
Hebar A; Rütgen BC; Selzer E
PLoS One; 2012; 7(9):e45015. PubMed ID: 23028738
[TBL] [Abstract][Full Text] [Related]
92. Focus on the Use of Resveratrol in Bladder Cancer.
Zucchi A; Claps F; Pastore AL; Perotti A; Biagini A; Sallicandro L; Gentile R; Caglioti C; Palazzetti F; Fioretti B
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901993
[TBL] [Abstract][Full Text] [Related]
93. Cytotoxic and Proapoptotic Effects of Resveratrol in In Vitro Studies on Selected Types of Gastrointestinal Cancers.
Ratajczak K; Borska S
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299624
[TBL] [Abstract][Full Text] [Related]
94. Targeting of cancer cell death mechanisms by resveratrol: a review.
Fu X; Li M; Tang C; Huang Z; Najafi M
Apoptosis; 2021 Dec; 26(11-12):561-573. PubMed ID: 34561763
[TBL] [Abstract][Full Text] [Related]
95. Resveratrol in Cancer Treatment with a Focus on Breast Cancer.
Kowsari H; Davoodvandi A; Dashti F; Mirazimi SMA; Bahabadi ZR; Aschner M; Sahebkar A; Gilasi HR; Hamblin MR; Mirzaei H
Curr Mol Pharmacol; 2023; 16(3):346-361. PubMed ID: 35713130
[TBL] [Abstract][Full Text] [Related]
96. Resveratrol Enhances the Radiosensitivity by Inducing DNA Damage and Antitumor Immunity in a Glioblastoma Rat Model under 3 T MRI Monitoring.
Qian L; Mao L; Mo W; Wang R; Zhang Y
J Oncol; 2022; 2022():9672773. PubMed ID: 36276282
[TBL] [Abstract][Full Text] [Related]
97. A mechanistic insight into the anticancer potentials of resveratrol: Current perspectives.
Bhuia MS; Chowdhury R; Akter MA; Ali MA; Afroz M; Akbor MS; Sonia FA; Mubarak MS; Islam MT
Phytother Res; 2024 May; ():. PubMed ID: 38768953
[TBL] [Abstract][Full Text] [Related]
98. A pH-Dependent rhodamine fluorophore with antiproliferative activity of bladder cancer in Vitro/Vivo and apoptosis mechanism.
Lu D; Yang T; Tang N; Li C; Song Y; Wang L; Wong WY; Yin SF; Xing Y; Kambe N; Qiu R
Eur J Med Chem; 2022 Jun; 236():114293. PubMed ID: 35385804
[TBL] [Abstract][Full Text] [Related]
99. The Green Anti-Cancer Weapon. The Role of Natural Compounds in Bladder Cancer Treatment.
Wigner P; Bijak M; Saluk-Bijak J
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360552
[TBL] [Abstract][Full Text] [Related]
100. New Nitric Oxide-Releasing Compounds as Promising Anti-Bladder Cancer Drugs.
Varela M; López M; Ingold M; Alem D; Perini V; Perelmuter K; Bollati-Fogolín M; López GV; Hernández P
Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
